The Roessler Liver microarray dataset (GSE14520) provides detailed clinical information; therefore, the correlation between AGR2 and various clinical parameters was statistically analyzed to define the role of sorafenib-regulated AGR2 in HCC progression (Tables 1–3). This evidence concerns the gene AGR2 and hepatocellular carcinoma.